Thursday, Isis announced trials that could get mipomersen approved in the rare genetic disease familial hypercholesterolemia (FH).

FORBES: Genzyme Eyes Isis Drug

It shows promise for all forms of high cholesterol, but the prospects are best in a rare disease called familial hypercholesterolemia (FH).

FORBES: Genzyme Inks Deal With Isis On Cholesterol Drug